title: Comparison of metaphase II oocytes after stimulation with recombinant follicle-stimulating hormone and urinary follicle-stimulating hormone in a pituitary down-regulation regimen.
authors.forename: Kuo-Chung
authors.initials: KC
authors.lastname: Lan
authors.forename: Yi-Chi
authors.initials: YC
authors.lastname: Lin
authors.forename: Fu-Jen
authors.initials: FJ
authors.lastname: Huang
authors.forename: Fu-Tsai
authors.initials: FT
authors.lastname: Kung
authors.forename: Chin-Hsiung
authors.initials: CH
authors.lastname: Hsieh
authors.forename: Shiuh Young
authors.initials: SY
authors.lastname: Chang
mesh_terms: D005260:Female; D005307:Fertilization in Vitro; D005640:Follicle Stimulating Hormone / Q000627:therapeutic use* / Q000652:urine; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D008297:Male; D008677:Metaphase / Q000187:drug effects / Q000502:physiology*; D009865:Oocytes / Q000166:cytology* / Q000187:drug effects; D016471:Ovarian Hyperstimulation Syndrome / Q000188:drug therapy; D011994:Recombinant Proteins / Q000494:pharmacology; D020554:Sperm Injections, Intracytoplasmic; D016896:Treatment Outcome
chemical_list: D011994:Recombinant Proteins; D005640:Follicle Stimulating Hormone; D016729:Leuprolide